- Home
- ICUI vs HHH Comparison
ICUI vs HHH Comparison
Compare ICUI & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- HHH
- Stock Information
- Founded
- ICUI 1984
- HHH 2010
- Country
- ICUI United States
- HHH United States
- Employees
- ICUI N/A
- HHH N/A
- Industry
- ICUI Medical/Dental Instruments
- HHH Real Estate Investment Trusts
- Sector
- ICUI Health Care
- HHH Real Estate
- Exchange
- ICUI Nasdaq
- HHH Nasdaq
- Market Cap
- ICUI 3.5B
- HHH 3.3B
- IPO Year
- ICUI 1992
- HHH N/A
- Fundamental
- Price
- ICUI $142.87
- HHH $69.89
- Analyst Decision
- ICUI Buy
- HHH Strong Buy
- Analyst Count
- ICUI 5
- HHH 2
- Target Price
- ICUI $197.50
- HHH $81.00
- AVG Volume (30 Days)
- ICUI 269.6K
- HHH 476.1K
- Earning Date
- ICUI 05-08-2025
- HHH 05-07-2025
- Dividend Yield
- ICUI N/A
- HHH 5.01%
- EPS Growth
- ICUI N/A
- HHH N/A
- EPS
- ICUI N/A
- HHH 5.21
- Revenue
- ICUI $2,382,046,000.00
- HHH $1,793,533,000.00
- Revenue This Year
- ICUI $0.84
- HHH N/A
- Revenue Next Year
- ICUI $2.91
- HHH $45.83
- P/E Ratio
- ICUI N/A
- HHH $13.43
- Revenue Growth
- ICUI 5.44
- HHH 106.40
- 52 Week Low
- ICUI $95.44
- HHH $59.46
- 52 Week High
- ICUI $196.26
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- ICUI 54.65
- HHH 54.75
- Support Level
- ICUI $131.73
- HHH $68.11
- Resistance Level
- ICUI $142.00
- HHH $71.47
- Average True Range (ATR)
- ICUI 5.87
- HHH 1.73
- MACD
- ICUI 0.68
- HHH 0.61
- Stochastic Oscillator
- ICUI 89.16
- HHH 79.29
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.